Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.900
-0.068 (-7.05%)
At close: Apr 28, 2026, 4:00 PM EDT
0.900
-0.000 (-0.04%)
Pre-market: Apr 29, 2026, 8:46 AM EDT
Oncolytics Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 15.41 | 10.1 | 12.18 | 8.49 | 10.52 | |
| Research & Development | 13.31 | 15.44 | 13.41 | 11.4 | 10.21 | |
| Operating Expenses | 28.73 | 25.54 | 25.59 | 19.89 | 20.73 | |
| Operating Income | -28.73 | -25.54 | -25.59 | -19.89 | -20.73 | |
| Interest & Investment Income | 0.39 | 0.98 | 1 | 0.39 | 0.08 | |
| Currency Exchange Gain (Loss) | -0.11 | 0.7 | -0.36 | 1.23 | -0.11 | |
| Other Non Operating Income (Expenses) | -0.24 | 1.17 | 4 | -0.01 | 0.01 | |
| EBT Excluding Unusual Items | -28.68 | -22.7 | -20.94 | -18.29 | -20.75 | |
| Pretax Income | -28.68 | -22.7 | -20.94 | -18.29 | -20.75 | |
| Income Tax Expense | 0.08 | 0.1 | 0.07 | 0.06 | 0.04 | |
| Net Income | -28.76 | -22.79 | -21.01 | -18.35 | -20.79 | |
| Net Income to Common | -28.76 | -22.79 | -21.01 | -18.35 | -20.79 | |
| Shares Outstanding (Basic) | 96 | 76 | 68 | 58 | 54 | |
| Shares Outstanding (Diluted) | 96 | 76 | 68 | 58 | 54 | |
| Shares Change (YoY) | 25.33% | 13.10% | 16.53% | 8.44% | 32.66% | |
| EPS (Basic) | -0.30 | -0.30 | -0.31 | -0.32 | -0.39 | |
| EPS (Diluted) | -0.30 | -0.30 | -0.31 | -0.32 | -0.39 | |
| Free Cash Flow | -20.12 | -20.06 | -21.55 | -17.3 | -17.95 | |
| Free Cash Flow Per Share | -0.21 | -0.26 | -0.32 | -0.30 | -0.34 | |
| EBITDA | -28.66 | -25.46 | -25.53 | -19.82 | -20.63 | |
| D&A For EBITDA | 0.07 | 0.09 | 0.06 | 0.07 | 0.1 | |
| EBIT | -28.73 | -25.54 | -25.59 | -19.89 | -20.73 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.